20200413_Sheridan_Vaccines-1.jpg
By Matt Sheridan | Jan. 18, 2021DTH Photo Illustration. The Rapidly Emerging Antiviral Drug Development Initiative is a new partnership at UNC-Chapel Hill that is aiming to develop drugs for future pandemic diseases.